Breast cancers treated with estrogen-depriving therapy were examined using fluorescent markers to highlight cancer cells (green), immune cells (red), cells that are actively dividing (yellow), and DNA, which marks the nucleus of every cell (blue). Credit: UT Southwestern Medical Center
Up to 20% of hormone receptor-positive breast cancers don’t respond to antiestrogen therapies. A study led by…